| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
CEO And CFO
1 company
Patel Snehal is a CEO And CFO at Greenwich LifeSciences, Inc.. Recent SEC Form 4 filings include 9 buys and 0 sells.
Estimated insider holdings value: $127.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 5,500 | $19.80 | $108,900.00 | +0.5% | |
| Feb 4, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 5,000 | $19.59 | $97,950.00 | +0.4% | |
| Jan 13, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,000 | $19.99 | $19,990.00 | - | |
| Jan 3, 2022 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,050 | $23.82 | $48,830.80 | +0.2% | |
| Dec 14, 2021 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 1,840 | $27.17 | $49,992.43 | +0.2% | |
| Apr 13, 2021 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,700 | $36.98 | $99,852.75 | +0.2% | |
| Nov 19, 2020 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 2,000 | $5.40 | $10,795.40 | +0.2% | |
| Sep 29, 2020 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 16,667 | $4.60 | $76,709.87 | +1.4% | |
| Sep 29, 2020 | GLSI Greenwich Lifesciences, Inc. | CEO And CFO | Buy | 114,347 | $5.75 | $657,495.25 | +15.3% |